Omalizumab for plant-food allergy from LTP or profilin
Treatments studied
Part of Immune system & allergy clinical trials.
This trial tests a drug called omalizumab for people with plant-food allergies caused by two specific proteins: LTP (found in peach skin) and profilin (found in melon). The goal is to see if the drug can help reduce allergic reactions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 55 years old.
- You have a plant-food allergy (like peach, melon) that has been confirmed with a skin test or blood test.
- Your allergy is caused by specific proteins called LTP or profilin.
- If you have an LTP allergy, previous treatment (IT-SL Pru p 3) has not helped.
- You are not pregnant or breastfeeding.
- You do not have severe eczema, uncontrolled asthma, or other serious medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to treat peach allergy in people who are allergic to a protein called LTP. It uses tiny microneedle patches to slowly introduce the allergen to help your body become less reactive.
This study tests a treatment that gradually exposes children to small amounts of peanut and certain tree nuts to reduce their allergy. It aims to help children safely tolerate multiple nuts at once.
This trial tests if omalizumab (Xolair) can improve skin reactions in people with food allergies. It may help reduce allergic symptoms triggered by foods like peanut, egg, or milk.
This trial tests if omalizumab (a drug that blocks allergy reactions) can help people with multiple food allergies. You might qualify if you have severe allergies to at least two foods like peanut, tree nuts, egg, or milk.
This study is testing whether a natural fiber called pectin can help people who are allergic to peach (and sometimes peanut) due to a specific protein (LTP). You would eat pectin every day for a while and then have food challenges to see if your allergy gets better.
This study tests if omalizumab (Xolair), an injectable medicine that blocks allergy antibodies, can help people with food allergies tolerate small amounts of their trigger foods. It's for people with high total IgE levels who were not eligible for a related study.
Hear when a new Food Allergies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.